U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C5H9O2.Zn
Molecular Weight 267.657
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZINC VALERATE

SMILES

[Zn++].CCCCC([O-])=O.CCCCC([O-])=O

InChI

InChIKey=BUDAIZWUWHWZPQ-UHFFFAOYSA-L
InChI=1S/2C5H10O2.Zn/c2*1-2-3-4-5(6)7;/h2*2-4H2,1H3,(H,6,7);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula C5H9O2
Molecular Weight 101.1238
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Zn
Molecular Weight 65.409
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Valeric acid is a colorless, oily liquid with an unpleasant odor. It is highly corrosive and must be handled with care. Valeric acid is mainly used as a chemical intermediate to manufacture flavors and perfumes, synthetic lubricants, agricultural chemicals, and pharmaceuticals. It is also used as a flavoring aid in foods. Valeric acid is considered safe as a food additive by the World Health Organization.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
[Percutaneous absorption of diflucortolone valerate in guinea pigs and man (author's transl)].
1976
Microflora-associated characteristics in faeces from allergic and nonallergic infants.
2000 Nov
Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil.
2001
Evidence for an essential arginine in the flavoprotein nitroalkane oxidase.
2001
The relation of oxidized LDL autoantibodies and long-term hormone replacement therapy to ultrasonographically assessed atherosclerotic plaque quantity and severity in postmenopausal women.
2001 Aug
Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease.
2001 Dec 14
Effect of the liquid upflow velocity on thermophilic sulphate reduction in acidifying granular sludge reactors.
2001 Feb
Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity.
2001 Feb
Effect of ruminal vs postruminal administration of degradable protein on utilization of low-quality forage by beef steers.
2001 Jan
Short- and long-term effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women.
2001 Jul
Biotin reagents for antibody pretargeting. 5. Additional studies of biotin conjugate design to provide biotinidase stability.
2001 Jul-Aug
Significance of substrate hydrophobicity for recognition by an oligopeptide transporter (PEPT1).
2001 Jul-Aug
Intravesical valrubicin in the treatment of carcinoma in situ of the bladder.
2001 Jun
Aroma-active components of nonfat dry milk.
2001 Jun
Births after transfer of zona-free blastocysts in oocyte donation cycles.
2001 Mar
Dehalogenation of dichloroethene in a contaminated soil: fatty acids and alcohols as electron donors and an apparent requirement for tetrachloroethene.
2001 Mar
A two-choice discrimination method to assess olfactory performance in pigtailed macaques, Macaca nemestrina.
2001 Mar
Production of poly(3-hydroxybutyrateco-3-hydroxyvalerate) from cottonseed oil and valeric acid in batch culture of Raistonia sp. strain JC-64.
2001 May
Comamonas nitrativorans sp. nov., a novel denitrifier isolated from a denitrifying reactor treating landfill leachate.
2001 May
Unusual enzymes involved in five pathways of glutamate fermentation.
2001 Oct
Cometabolic biosynthesis of copolyesters consisting of 3-hydroxyvalerate and medium-chain-length 3-hydroxyalkanoates by Pseudomonas sp. DSY-82.
2001 Oct
beta-Oxidation of simvastatin in mouse liver preparations.
2001 Oct
Rumen microbial sequestration of [2-(13)C]acetate in cattle.
2001 Sep
Effect of casein infusion in the rumen, duodenum or both sites on factors affecting forage intake and performance of dairy cows fed red clover-grass silage.
2002 Apr
Effects of culture conditions on the production of polyhydroxyalkanoates by Azotobacter chroococcum H23 in media containing a high concentration of alpechín (wastewater from olive oil mills) as primary carbon source.
2002 Aug 7
Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial.
2002 Dec 21-28
Mesophilic acidification of gelatinaceous wastewater.
2002 Feb 14
Carvacrol and thymol reduce swine waste odor and pathogens: stability of oils.
2002 Jan
Volatile flavor components of stored nonfat dry milk.
2002 Jan 16
Development of a headspace solid-phase microextraction-gas chromatography-mass spectrometry method for the identification of odour-causing volatile compounds in packaging materials.
2002 Jul 19
A rapid selective extraction procedure for the outer membrane protein (OmpF) from Escherichia coli.
2002 Jun
Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis.
2002 Jun
NutriDense and waxy corn hybrids: effects on site and extent of disappearance of nutrients in sheep.
2002 May
Acylated triterpenoid saponins from the stem bark of Foetidia africana.
2002 Nov
Polymers for biodegradable medical devices XI. Microencapsulation studies: characterization of hydrocortisone-loaded poly-hydroxybutyrate-hydroxyvalerate microspheres.
2002 Nov-Dec
Production of specific copolymers of polyhydroxyalkanoates from industrial waste.
2002 Spring
Hydrogen production from wastewater by acidogenic granular sludge.
2003
Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial.
2003 Jul
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.
2003 Mar 28
Left ventricular diastolic function assessment by tissue Doppler echocardiography in relation to hormonal replacement therapy in postmenopausal women with diastolic dysfunction.
2003 Mar-Apr
[Anti-arrhythmia activity of estradiol valerate and estradiol nitrate].
2003 May-Jun
Regulation of glucose-6-phosphatase gene expression in cultured hepatocytes and H4IIE cells by short-chain fatty acids: role of hepatic nuclear factor-4alpha.
2003 Oct 17
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
1.5 mM valeric acid is an effective chemical reagent to increase mAb production in rCHO cells.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:02:33 GMT 2023
Edited
by admin
on Fri Dec 15 16:02:33 GMT 2023
Record UNII
HHJ036TQR0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZINC VALERATE
MI   WHO-DD  
Systematic Name English
PENTANOIC ACID ZINC SALT
Common Name English
ZINC VALERIANATE
Common Name English
ZINC VALERATE [MI]
Common Name English
Zinc Valerate [WHO-DD]
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
209-124-1
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
PUBCHEM
68393
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
RXCUI
1546360
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY RxNorm
EPA CompTox
DTXSID00890509
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
MERCK INDEX
m11634
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY Merck Index
DAILYMED
HHJ036TQR0
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
CAS
556-38-7
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
SMS_ID
100000145791
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
FDA UNII
HHJ036TQR0
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
EVMPD
SUB124575
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY